Factors Associated with Length of Stay at Home in the Final Month of Life among Advanced Cancer Patients: A Retrospective Chart Review

2017 ◽  
Vol 20 (8) ◽  
pp. 884-889 ◽  
Author(s):  
Masatomo Otsuka
Keyword(s):  
Length Of Stay ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Advanced Cancer Patients ◽  
Factors Associated ◽  
At Home

scholarly journals Incidence and Cause of Delirium in Hospitalized Patients between the Ages of 18 and 56: A Retrospective Chart Review

2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
Michelle T. Weckmann ◽  
Camden Bay ◽  
Nesrin Abu Ata ◽  
R. Sean Morrison
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Total Hospital Cost ◽  
Advanced Cancer Patients ◽  
Total Hospital ◽  
Elderly Cancer Patients ◽  
Lung Malignancy ◽  
Distressing Condition

Background. Delirium is a common and devastating condition which has been well characterized in elderly cancer patients, but little is known about delirium in cancer patients under the age of 65. Aim. A pilot study to explore the incidence and potential causes of delirium in hospitalized advanced cancer patients at the age of 18–56 years. Design. A retrospective chart review using validated instruments was used to examine the charts of hematology-oncology admissions in a large academic institution. Data was collected as to the likelihood of delirium and potential precipitants. Results. Delirium incidence was 29% among advanced cancer patients. The associated precipitants of delirium were multifactorial, the most common being medications and infection. Delirium was more common in patients admitted for either acute symptom management or the presence of a lung malignancy. Patients with delirium demonstrated significantly increased total hospital cost and a borderline significant result for increased mortality compared to those without delirium. Conclusions. Delirium is common in hospitalized advanced cancer patients (age 18–56 years) and the cause is typically multifactorial. Delirium results in a more complicated hospital course and likely increased mortality. Further research is needed to define strategies to prevent and treat this common and distressing condition.

Clinical and demographic factors associated to the place of death in advanced cancer patients assisted at home in Italy

2014 ◽  
Vol 23 (2) ◽  
pp. 61-67 ◽  
Author(s):  
Silvia Varani ◽  
Filippo G Dall'Olio ◽  
Rossana Messana ◽  
Stephan Tanneberger ◽  
Raffaella Pannuti ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Demographic Factors ◽  
Place Of Death ◽  
Advanced Cancer Patients ◽  
Factors Associated ◽  
At Home

scholarly journals Palliative Care and COVID-19 Pandemic: Retrospective Study of Factors Associated With Infection and Death at an Oncological Palliative Care Reference Center

2021 ◽  
pp. 104990912098696
Author(s):  
Livia Costa de Oliveira ◽  
Karla Santos da Costa Rosa ◽  
Ana Luísa Durante ◽  
Luciana de Oliveira Ramadas Rodrigues ◽  
Daianny Arrais de Oliveira da Cunha ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Palliative Care ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Karnofsky Performance Status ◽  
Performance Status ◽  
Tumor Type ◽  
Advanced Cancer Patients ◽  
Factors Associated ◽  
Reactive Protein

Background: Advanced cancer patients are part of a group likely to be more susceptible to COVID-19. Aims: To describe the profile of advanced cancer inpatients to an exclusive Palliative Care Unit (PCU) with the diagnosis of COVID-19, and to evaluate the factors associated with death in these cases. Design: Retrospective cohort study with data from advanced cancer inpatients to an exclusive PCU, from March to July 2020, with severe acute respiratory syndrome. Diagnostic of COVID-19 and death were the dependent variables. Logistic regression analyses were performed, with the odds ratio (OR) and 95% confidence interval (CI). Results: One hundred fifty-five patients were selected. The mean age was 60.9 (±13.4) years old and the most prevalent tumor type was breast (30.3%). Eighty-three (53.5%) patients had a diagnostic confirmation of COVID-19. Having diabetes mellitus (OR: 2.2; 95% CI: 1.1-6.6) and having received chemotherapy in less than 30 days before admission (OR: 3.8; 95% CI: 1.2-12.2) were associated factors to diagnosis of COVID-19. Among those infected, 81.9% died and, patients with Karnofsky Performance Status (KPS) < 30% (OR: 14.8; 95% CI 2.7-21.6) and C-reactive protein (CRP) >21.6mg/L (OR: 9.3; 95% CI 1.1-27.8), had a greater chance of achieving this outcome. Conclusion: Advanced cancer patients who underwent chemotherapy in less than 30 days before admission and who had diabetes mellitus were more likely to develop Coronavirus 2019 disease. Among the confirmed cases, those hospitalized with worse KPS and bigger CRP were more likely to die.

Age differences in the last week of life in advanced cancer patients followed at home

2015 ◽  
Vol 24 (4) ◽  
pp. 1889-1895 ◽  
Author(s):  
Sebastiano Mercadante ◽  
Federica Aielli ◽  
Francesco Masedu ◽  
Marco Valenti ◽  
Lucilla Verna ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Age Differences ◽  
Advanced Cancer Patients ◽  
At Home

scholarly journals Home Artificial Nutrition in Advanced Cancer

1997 ◽  
Vol 90 (11) ◽  
pp. 597-603 ◽  
Author(s):  
Loris Pironi ◽  
Enrico Ruggeri ◽  
Stephan Tanneberger ◽  
Stefano Giordani ◽  
Franco Pannuti ◽  
...  
Keyword(s):  
Enteral Nutrition ◽  
Parenteral Nutrition ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Performance Status ◽  
Artificial Nutrition ◽  
Utilization Rate ◽  
Karnofsky Performance Score ◽  
Advanced Cancer Patients ◽  
At Home

Attitudes to home artificial nutrition (HAN) in cancer vary greatly from country to country. A 6-year prospective survey of the practice of HAN in advanced cancer patients applied by a hospital-at-home programme in an Italian health district was performed to estimate the utilization rate, to evaluate efficacy in preventing death from cachexia, maintaining patients at home without burdens and distress and improving patients' performance status, and to obtain information about costs. Patients were eligible for HAN when all the following were present: hypophagia; life expectancy 6 weeks or more, suitable patient and family circumstances; and verbal informed consent. From July 1990 to June 1996, 587 patients were evaluated; 164 were selected for HAN (135 enteral and 29 parenteral) and were followed until 31 December 1996. The incidence of HAN per million inhabitants was 18.4 in the first year of activity and 33.2–36.9 in subsequent years, being 4–10 times greater than rates reported by the Italian HAN registers. On 31 December 1996, 158 patients had died because of the disease and 6 were on treatment. Mean survival was 17.2 weeks for those on enteral nutrition and 12.2 weeks for those on parenteral nutrition. Prediction of survival was 72% accurate. 95 patients had undergone 155 readmissions to hospital, where they spent 15–23% of their survival time. Burdens due to HAN were well accepted by 124 patients, an annoyance or scarcely tolerable in the remainder. The frequency of major complications of parenteral nutrition was 0.67 per year for catheter sepsis and 0.16 per year for deep vein thrombosis. Karnofsky performance score increased in only 13 patients and body weight increased in 43. The fixed direct costs per patient-day (in European Currency Units) were 14.2 for the nutrition team, 18.2 for enteral nutrition and 61 for parenteral nutrition. The results indicate that definite entry criteria and local surveys are required for the correct use of HAN in advanced cancer patients, that HAN can be applied without causing additional burdens and distress, and that its costs are not higher than hospital costs.

scholarly journals Palliative Sedation in Advanced Cancer Patients Followed at Home: A Retrospective Analysis

2012 ◽  
Vol 43 (6) ◽  
pp. 1126-1130 ◽  
Author(s):  
Sebastiano Mercadante ◽  
Giampiero Porzio ◽  
Alessandro Valle ◽  
Flavio Fusco ◽  
Federica Aielli ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Palliative Sedation ◽  
Advanced Cancer Patients ◽  
At Home
Sign in / Sign up

Export Citation Format

Share Document